Birgit Blechert

806 total citations
16 papers, 667 citations indexed

About

Birgit Blechert is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Birgit Blechert has authored 16 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Birgit Blechert's work include Radiopharmaceutical Chemistry and Applications (10 papers), Medical Imaging Techniques and Applications (5 papers) and Peptidase Inhibition and Analysis (3 papers). Birgit Blechert is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (10 papers), Medical Imaging Techniques and Applications (5 papers) and Peptidase Inhibition and Analysis (3 papers). Birgit Blechert collaborates with scholars based in Germany, Sweden and Italy. Birgit Blechert's co-authors include Markus Essler, Florian Gaertner, Rainer Jordan, Robert Luxenhofer, Christof Seidl, Klaus‐Peter Janssen, Frank Bruchertseifer, Jan Mueller, Reingard Senekowitsch–Schmidtke and Markus Schwaiger and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

In The Last Decade

Birgit Blechert

16 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birgit Blechert Germany 12 214 168 130 127 126 16 667
Quido G. de Lussanet Netherlands 12 311 1.5× 180 1.1× 85 0.7× 98 0.8× 38 0.3× 24 648
Marie-Hélène Gagnon United States 13 245 1.1× 289 1.7× 109 0.8× 132 1.0× 122 1.0× 29 877
Chengyan Dong China 18 324 1.5× 230 1.4× 127 1.0× 173 1.4× 43 0.3× 30 881
Le-Cun Xu United States 8 172 0.8× 226 1.3× 80 0.6× 246 1.9× 93 0.7× 12 608
Alexander Zheleznyak United States 16 309 1.4× 352 2.1× 85 0.7× 298 2.3× 41 0.3× 26 945
Sarah M. Cheal United States 19 490 2.3× 320 1.9× 147 1.1× 285 2.2× 85 0.7× 36 1.0k
Kent R. Buhler United States 16 155 0.7× 503 3.0× 129 1.0× 288 2.3× 71 0.6× 22 1.0k
Nhat Le United States 15 481 2.2× 202 1.2× 62 0.5× 189 1.5× 31 0.2× 27 709
Monika Sima United States 13 146 0.7× 281 1.7× 404 3.1× 233 1.8× 114 0.9× 18 838
Yesen Li China 15 230 1.1× 307 1.8× 100 0.8× 171 1.3× 71 0.6× 45 766

Countries citing papers authored by Birgit Blechert

Since Specialization
Citations

This map shows the geographic impact of Birgit Blechert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Blechert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Blechert more than expected).

Fields of papers citing papers by Birgit Blechert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Blechert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Blechert. The network helps show where Birgit Blechert may publish in the future.

Co-authorship network of co-authors of Birgit Blechert

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Blechert. A scholar is included among the top collaborators of Birgit Blechert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Blechert. Birgit Blechert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Morath, Volker, Birgit Blechert, Dominik Summer, et al.. (2023). Molecular Design of 68Ga- and 89Zr-Labeled Anticalin Radioligands for PET-Imaging of PSMA-Positive Tumors. Molecular Pharmaceutics. 20(5). 2490–2501. 3 indexed citations
2.
D’Alessandria, Calogero, Sten Braesch‐Andersen, Sybille Reder, et al.. (2016). Noninvasive In Vivo Imaging and Biologic Characterization of Thyroid Tumors by ImmunoPET Targeting of Galectin-3. Cancer Research. 76(12). 3583–3592. 19 indexed citations
3.
Pfob, Christian H., Sibylle Ziegler, Frank Philipp Graner, et al.. (2016). Biodistribution and radiation dosimetry of 68Ga-PSMA HBED CC—a PSMA specific probe for PET imaging of prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 43(11). 1962–1970. 66 indexed citations
4.
Feuchtinger, Annette, Irina Heid, Michaela Aichler, et al.. (2016). Tumor Uptake of Anti-CD20 Fabs Depends on Tumor Perfusion. Journal of Nuclear Medicine. 57(12). 1971–1977. 18 indexed citations
5.
Feuerecker, Benedikt, Guido Piontek, Christof Seidl, et al.. (2015). Effects of topoisomerase inhibitors that induce DNA damage response on glucose metabolism and PI3K/Akt/mTOR signaling in multiple myeloma cells.. PubMed. 5(5). 1649–64. 36 indexed citations
6.
Seidl, Christof, Birgit Blechert, Florian Gaertner, et al.. (2014). α-Radioimmunotherapy with 213Bi-anti-CD38 immunoconjugates is effective in a mouse model of human multiple myeloma. Oncotarget. 6(7). 4692–4703. 38 indexed citations
7.
Pickhard, Anja, Guido Piontek, Christof Seidl, et al.. (2013). 213Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cells. Nuclear Medicine and Biology. 41(1). 68–76. 7 indexed citations
8.
Essler, Markus, Frauke Neff, Birgit Blechert, et al.. (2012). Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis. European Journal of Nuclear Medicine and Molecular Imaging. 39(4). 602–612. 61 indexed citations
9.
Vallon, Mario, Christof Seidl, Birgit Blechert, et al.. (2012). Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest. European Journal of Nuclear Medicine and Molecular Imaging. 39(12). 1886–1897. 16 indexed citations
10.
Drecoll, Enken, Florian Gaertner, Matthias Miederer, et al.. (2009). Treatment of Peritoneal Carcinomatosis by Targeted Delivery of the Radio-Labeled Tumor Homing Peptide 213Bi-DTPA-[F3]2 into the Nucleus of Tumor Cells. PLoS ONE. 4(5). e5715–e5715. 45 indexed citations
11.
Gaertner, Florian, et al.. (2009). Endogenous expression of the sodium iodide symporter mediates uptake of iodide in murine models of colorectal carcinoma. International Journal of Cancer. 125(12). 2783–2791. 9 indexed citations
12.
Mueller, Jan, Florian Gaertner, Birgit Blechert, Klaus‐Peter Janssen, & Markus Essler. (2009). Targeting of Tumor Blood Vessels: A Phage-Displayed Tumor-Homing Peptide Specifically Binds to Matrix Metalloproteinase-2-Processed Collagen IV and Blocks Angiogenesis In vivo. Molecular Cancer Research. 7(7). 1078–1085. 45 indexed citations
13.
Gaertner, Florian, Robert Luxenhofer, Birgit Blechert, Rainer Jordan, & Markus Essler. (2007). Synthesis, biodistribution and excretion of radiolabeled poly(2-alkyl-2-oxazoline)s. Journal of Controlled Release. 119(3). 291–300. 201 indexed citations
14.
Weber, Georg F., Florian Gaertner, Wolfgang Erl, et al.. (2006). IL-22-Mediated Tumor Growth Reduction Correlates with Inhibition of ERK1/2 and AKT Phosphorylation and Induction of Cell Cycle Arrest in the G2-M Phase. The Journal of Immunology. 177(11). 8266–8272. 70 indexed citations
15.
Schultheiß, Caroline, Birgit Blechert, Florian Gaertner, et al.. (2006). In vivo characterization of endothelial cell activation in a transgenic mouse model of Alzheimer’s disease. Angiogenesis. 9(2). 59–65. 32 indexed citations
16.
Stahl, Alexander, Jens Lutz, Bettina Wagner, et al.. (2006). Probenecid reduces renal uptake of 111In-DOTATOC in rats. 47. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Quido G. de Lussanet Breakdown of academic impact, for papers by Marie-Hélène Gagnon Breakdown of academic impact, for papers by Chengyan Dong Breakdown of academic impact, for papers by Le-Cun Xu Breakdown of academic impact, for papers by Alexander Zheleznyak Breakdown of academic impact, for papers by Sarah M. Cheal Breakdown of academic impact, for papers by Kent R. Buhler Breakdown of academic impact, for papers by Nhat Le Breakdown of academic impact, for papers by Monika Sima Breakdown of academic impact, for papers by Yesen Li
Rankless by CCL
2026